NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $908,000 | -23.5% | 26,600 | +8.1% | 0.61% | -31.4% |
| Q3 2021 | $1,187,000 | +6.8% | 24,600 | 0.0% | 0.89% | +2.5% |
| Q2 2021 | $1,111,000 | -3.6% | 24,600 | +2.9% | 0.87% | -9.0% |
| Q1 2021 | $1,153,000 | +2.9% | 23,900 | +14.9% | 0.96% | -5.1% |
| Q4 2020 | $1,120,000 | +37.9% | 20,800 | -5.5% | 1.01% | +32.8% |
| Q3 2020 | $812,000 | +37.9% | 22,000 | +15.8% | 0.76% | +43.8% |
| Q2 2020 | $589,000 | +12.2% | 19,000 | 0.0% | 0.53% | -0.6% |
| Q1 2020 | $525,000 | -5.6% | 19,000 | 0.0% | 0.53% | +77.6% |
| Q4 2019 | $556,000 | +58.9% | 19,000 | +3.8% | 0.30% | +59.0% |
| Q3 2019 | $350,000 | -12.9% | 18,300 | 0.0% | 0.19% | +23.7% |
| Q2 2019 | $402,000 | +12.3% | 18,300 | +4.6% | 0.15% | +31.0% |
| Q1 2019 | $358,000 | +62.0% | 17,500 | 0.0% | 0.12% | +58.9% |
| Q4 2018 | $221,000 | – | 17,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |